Monday, June 25, 2018 8:00 PM EDT
On a day where broad markets are correcting strongly we are on record forecasting a bullish second half of 2018 for biotechnology stocks. This is why we believe biotechnology stocks will outperform broad stock markets in the 2n half of 2018.
Let’s take one step back. Biotech was the absolute stock market darling between 2010 and summer 2015. Since then the biotech index represented by the IBB ETF corrected 39%.
As always after such a long and deep retracement it takes away every bullishness among investors and media. Case in point: this recent bearish article on Bloomberg. Consequently, the vast majority of investors forget about this sector.
Interestingly, exactly at a time when ‘nobody is paying attention’ it is when the new bull market gets born. That’s the law of markets, and that’s when the minority of smart investors start taking long positions in a gradual and discrete way.
In January of 2018 we observed that the process we just discussed was taking place.In Biotechnology Stocks Bullish But This Is The Most Important Week Of 2018 we observed that magic was happening in the biotech space.
We wrote: “If the 112 level on the IBB chart holds strong next week it suggests the biotechnology space will continue its secular new bull market after it take a breather between 2015 and … this week.”
Since then, the biotech sector corrected slightly, but continued to trade in a tight range.
Interestingly, the chart pattern that is unfolding is a clear cup-and-handle pattern. This is a very powerful, and very bullish in most case, pattern. That’s why we expect to see this sector outperform broad markets in the second half of 2018.
Which biotech stocks to look into? Check our team’s 4 Biotechnology Stocks Worth Considering In 2018 written earlier this year.
(Click on image to enlarge)
Disclaimer: InvestingHaven.com makes every effort to ensure that the information provided is complete, correct, accurate and ...
more
Disclaimer: InvestingHaven.com makes every effort to ensure that the information provided is complete, correct, accurate and updated.In spite of these efforts, errors may occur in the information provided.If the information provided contains errors or if certain information is not available on or via the site, InvestingHaven.com will make every effort to rectify the situation as soon as possible. However, InvestingHaven.com cannot be held liable for direct or indirect damages resulting from the use of the information on this site. If you notice any errors in the information provided via the site, please contact the manager of the site.
Moreover, the views expressed in the articles (posts) on this website are the ones from the authors and are for information only. It is not intended as an offer, invitation, or solicitation to buy or sell any of any security or asset described. Nor the website manager nor the authors do accept any liability whatsoever for any direct or consequential loss arising from the use of their content. Please consult a qualified financial advisor before making investments. The information on this website and in the articles (posts) is believed to be reliable , but the authors do not make any representations as to its accuracy or completeness.
The content of the site (including links) may be adjusted, changed or expanded at any time without notice. InvestingHaven.com does not guarantee the proper functioning of the website and cannot be held liable in any way for the improper functioning or temporary (un)availability of the website or for any form of damage, direct or indirect, which may be the result of access to or use of the website.
InvestingHaven.com cannot be held liable under any circumstances by anyone, directly or indirectly, in any specific or other way, for damages resulting from the use of this site or any other site connected by means of links or hyperlinks, including, without limitation, any losses, interruptions of work, damage to programmes or other information on the computer system or to equipment, software or other items owned by the user.
less
How did you like this article? Let us know so we can better customize your reading experience.